Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (278)	7/24/2001 3:42:20 PM
From: tom pope	Read Replies (2) of 1005

This is Marketwatch's take, Tuck: >>Arena Pharmaceuticals (ARNA: news, chart, profile) shares plunged 20 percent Tuesday morning after the company posted a second-quarter loss, while analysts were looking for a profit. The company reported losses of $2.1 million, or 9 cents per share, excluding charges, less than losses of 21 cents per share in the year-earlier period. However, analysts had been expecting the company to turn a profit of 2 cents a share. Revenue increased 158 percent over last year to $3.3 million.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next